Cell-to-Cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Endocrine journal

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1507/ENDOCRJ.49.483PMID 12402981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Minireview: the OPG/RANKL/RANK system.

  2001cited by this paper
• Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.

  2001cited by this paper
• Intercellular Adhesion Molecule 1 Discriminates Functionally Different Populations of Human Osteoblasts: Characteristic Involvement of Cell Cycle Regulators

  2000cited by this paper
• A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.

  1999cited by this paper
• Detection of low-affinity adhesion ligands by linking recombinant cell adhesion molecules in uniform orientation to a fluorescently labelled dextran molecule by means of hexahistidine tagging: the case of multimeric CD40.

  1998cited by this paper
• Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.

  1998cited by this paper
• Involvement of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 in osteoclastogenesis: a possible role in direct interaction between osteoclast precursors.

  1998cited by this paper
• Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone.

  1998cited by this paper
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

  1998cited by this paper
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997cited by this paper
• Involvement of alpha5beta1 integrin in matrix interactions and proliferation of chondrocytes.

  1997cited by this paper
• A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

  1997cited by this paper
• Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.

  1997cited by this paper
• Integrin Expression and Function on Human Osteoblast‐like Cells

  1997cited by this paper
• A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.

  1997cited by this paper
• Expression of the cell‐adhesion molecule VCAM‐1 by stromal cells is necessary for osteoclastogenesis

  1997cited by this paper
• TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells*

  1997cited by this paper
• Involvement of α5β1 Integrin in Matrix Interactions and Proliferation of Chondrocytes

  1997cited by this paper
• Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact.

  1996cited by this paper
• Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts

  1996cited by this paper
• Modulation of osteoclast differentiation by local factors.

  1995cited by this paper
• The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow.

  1995cited by this paper
• Retinoic acid inhibits basal and interferon‐γ‐induced expression of intercellular adhesion molecule 1 in monocytic cells

  1995cited by this paper
• Osteoblasts are regulated by the cellular adhesion through ICAM‐1 and VCAM‐1

  1995cited by this paper
• Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers.

  1995cited by this paper
• Transcriptional Regulation of the Intercellular Adhesion Molecule-1 Gene by Inflammatory Cytokines in Human Endothelial Cells

  1995cited by this paper
• Integrins and osteoclastic resorption in three bone organ cultures: Differential sensitivity to synthetic arg‐gly‐asp peptides during osteoclast formation

  1994cited by this paper
• Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1.

  1994cited by this paper
• T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ

  1993cited by this paper
• T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta.

  1993cited by this paper
• Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein.

  1993cited by this paper
• Role of cytokines in bone resorption

  1993cited by this paper
• Integrin expression in human bone

  1993cited by this paper
• Involvement of adhesion molecules LFA-1 and ICAM-1 in osteoclast development.

  1993cited by this paper
• Insulin-like growth factor-I supports formation and activation of osteoclasts.

  1992cited by this paper
• Integrin subunit expression by human osteoblasts and osteoclasts in situ and in culture.

  1992cited by this paper
• Echistatin is a potent inhibitor of bone resorption in culture

  1990cited by this paper
• The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.

  1989cited by this paper
• Local and systemic factors in the pathogenesis of osteoporosis.

  1988cited by this paper
• Local and systemic factors in the pathogenesis of osteoporosis.

  1988cited by this paper
• Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).

  1986cited by this paper
• Bone cell differentiation and growth factors.

  1983cited by this paper
• Target cells in bone for parathormone and calcitonin are different: enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces.

  1975cited by this paper
• BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE.

  1965cited by this paper

• Inflammation and Dysregulated Bone Turnover Confound Serum ICAM-1 as a Cardiovascular Marker in Hemodialysis

  2026cites this paper
• Cellular Crosstalk Between Periodontal Ligament Fibroblasts and Macrophages: Insights from 2D and 3D Culture Systems in External Inflammatory Root Resorption.

  2025cites this paper
• Extracellular Vesicle-Mediated Bone Remodeling and Bone Metastasis: Implications in Prostate Cancer.

  2021cites this paper
• Effects of Advanced Glycation End Products on Differentiation and Function of Osteoblasts and Osteoclasts

  2021cites this paper
• PTH(1-34) activates the migration and adhesion of BMSCs through the rictor/mTORC2 pathway

  2020cites this paper
• Integrins and other cell surface attachment molecules of bone cells

  2020cites this paper
• Effect of intercellular adhesion molecule 1 deficiency on the development of apical periodontitis.

  2020cites this paper
• Vdr expression in osteoclast precursors is not critical in bone homeostasis.

  2019cites this paper
• BISPHOSPHONATES FOR THE TREATMENT OF CALCITRIOL-INDUCED HYPERCALCEMIA.

  2019cites this paper
• Etidronate prevents dystrophic cardiac calcification by inhibiting macrophage aggregation

  2018cites this paper
• Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.

  2017cites this paper
• Systemic vitamin D supplementation and local bone formation after maxillary sinus augmentation - a randomized, double-blind, placebo-controlled clinical investigation.

  2016cites this paper
• Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidence.

  2016cites this paper
• Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro.

  2015cites this paper
• Original Article Osteoblastic NF-κB pathway is involved in 1α, 25(OH) 2 D 3 -induced osteoclast-like cells formation in vitro

  2015cites this paper
• Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy

  2015cites this paper
• Repercussions of NSAIDS drugs on bone tissue: the osteoblast.

  2015cites this paper
• Role of the Vitamin D Receptor in MDR1/P-glycoprotein Regulation at the Blood-brain Barrier

  2014cites this paper
• Relationships Between Inflammation, Immune Activation, and Bone Health Among HIV-Infected Adults on Stable Antiretroviral Therapy

  2014cites this paper
• TNF-α induces matrix metalloproteinase-9-dependent soluble intercellular adhesion molecule-1 release via TRAF2-mediated MAPKs and NF-κB activation in osteoblast-like MC3T3-E1 cells

  2014cites this paper
• Osteocytes and Osteoclasts, a Relationship Under Strain

  2014cites this paper
• STATs and macrophage fusion

  2013cites this paper
• The pleiotropic effects of vitamin D in bone.

  2013cites this paper
• Comparative effects of 1α‐hydroxyvitamin D3 and 1,25‐dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(‐/‐) mice

  2013cites this paper
• Tunneling nanotube formation is essential for the regulation of osteoclastogenesis

  2013cites this paper
• RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

  2012cites this paper
• Sex‐specific effects of estrogen and androgen on gene expression in human monocyte‐derived osteoclasts

  2011cites this paper
• Molecules Regulating Macrophage Fusions

  2011cites this paper
• Target Genes: Bone Proteins

  2011cites this paper
• Chapter 23 – Target Genes: Bone Proteins

  2011cites this paper
• New and emerging antiresorptive treatments in osteoporosis.

  2011cites this paper
• Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα12 or constitutively active RhoA

  2010cites this paper
• Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.

  2010cites this paper
• Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption.

  2009cites this paper
• Intercellular adhesion molecule-1 clusters during osteoclastogenesis.

  2009cites this paper
• Osteoclastos en el hueso alveolar y las moléculas de adhesión intercelular (icam-1). En células del ligamento periodontal durante el estrés mecánico, en ratas tratadas con diclofenaco o nimesulide

  2009influential citation
• Direct cell–cell contact between periodontal ligament fibroblasts and osteoclast precursors synergistically increases the expression of genes related to osteoclastogenesis

  2009cites this paper
• An active role for soluble and membrane intercellular adhesion molecule-1 in osteoclast activity in vitro

  2008cites this paper
• Histomorphometric analysis of the intramedullary bone response to titanium particles in wild-type and IL-1R1 knock-out mice: a preliminary study.

  2008cites this paper
• Proteomic profile of osteoclast membrane proteins: Identification of Na+/H+ exchanger domain containing 2 and its role in osteoclast fusion

  2008cites this paper
• Chapter 20 – Integrins and Other Cell Surface Attachment Molecules of Bone Cells

  2008cites this paper
• The role of Mac‐1 (CD11b/CD18) in osteoclast differentiation induced by receptor activator of nuclear factor‐κB ligand

  2008cites this paper
• The skeleton as an intracrine organ for vitamin D metabolism.

  2008cites this paper
• The molecular basis of macrophage fusion.

  2008cites this paper
• Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation

  2007cites this paper
• Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1.

  2007cites this paper
• Evidence for two distinct pathways in TNFalpha-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients.

  2007cites this paper
• In Vitro Ossification and Remodeling of Mineralized Collagen I Scaffolds

  2006cites this paper
• Eosinophil Chemotactic Factor‐L (ECF‐L) Enhances Osteoclast Formation by Increasing ICAM‐1 Expression

  2006cites this paper
• CHAPTER 8 – Integrins and Other Adhesion Molecules

  2006cites this paper
• Untersuchung zur Acidierung des Harns mittels alimentärer Calciumchlorid-Gabe bei tragenden Sauen

  2006cites this paper
• Novel roles of bone lining cells in bone remodeling

  2005cites this paper
• Immunocompetent Properties of Human Osteoblasts: Interactions With T Lymphocytes

  2005cites this paper
• Expression of ICAM-1 by osteoblasts in healthy individuals and in patients suffering from osteoarthritis and osteoporosis.

  2004cites this paper
• Immune signals in the context of secondary osteoporosis.

  2004cites this paper
• Inter- and intracellular signaling in secondary osteoporosis

  2003cites this paper
• Integrins and Other Cell Surface Attachment Molecules of Bone Cells

  2002cites this paper
• World Journal of Clinical Oncology

  year unknowncites this paper